Radiopharm Theranostics Limited (RAD.AX)
ASX - ASX Delayed price. Currency in AUD
Add to watchlist
At close: 04:10PM AEST
| Previous close | 0.0270 |
| Open | 0.0270 |
| Bid | 0.0260 x N/A |
| Ask | 0.0270 x N/A |
| Day's range | 0.0260 - 0.0270 |
| 52-week range | 0.0260 - 0.1464 |
| Volume | |
| Avg. volume | 4,553,568 |
| Market cap | 58.67M |
| Beta (5Y monthly) | 0.82 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.1200 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 0.62 |
Simply Wall St.Radiopharm Theranostics Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags
Radiopharm Theranostics ( ASX:RAD ) Full Year 2024 Results Key Financial Results Net loss: AU$47.9m (loss widened by...
Simply Wall St.Radiopharm Theranostics Non-Executive Director Acquires 430% More Stock
Potential Radiopharm Theranostics Limited ( ASX:RAD ) shareholders may wish to note that the Non-Executive Director...
GlobeNewswireRadiopharm Receives Strategic Investment for up to A$18 million
Lantheus has agreed to make an initial strategic equity investment of A$7.5 million in RadiopharmOffer price for the shares of A$0.05 represents a 47% premium to the last closing price of $0.034 on 19 June 2024Option for Lantheus to invest a further A$7.5m within 6 months on the same termsLantheus will also secure rights to two early preclinical assets in exchange for an A$3m upfront payment pursuant to a transfer and development agreement SYDNEY, June 20, 2024 (GLOBE NEWSWIRE) -- Radiopharm The
© 2024 Yahoo. All rights reserved.